Related Experiment Video
Updated: Jul 11, 2026

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
Published on: May 31, 2017
TWEAK and the central nervous system
1Department of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA. myepes@emory.edu
Abstract:
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a member of the tumor necrosis factor superfamily that acts on responsive cells via binding to a cell surface receptor named fibroblast growth factor-inducible 14 (Fn14). TWEAK can regulate numerous cellular responses in vitro and in vivo. Recent studies have indicated that TWEAK and Fn14 are expressed in the central nervous system (CNS), and that in response to a variety of stimuli, including cerebral ischemia, there is an increase in TWEAK and Fn14 expression in perivascular astrocytes, microglia, endothelial cells, and neurons with subsequent increase in the permeability of the blood-brain barrier (BBB) and cell death. Furthermore, there is a growing body of evidence indicating that TWEAK induces the activation of the NF-kappaB in the CNS with release of proinflammatory cytokines and matrix metalloproteinases. In addition, inhibition of TWEAK activity by either treatment with a Fn14-Fc fusion protein or neutralizing anti-TWEAK antibodies has shown therapeutic efficacy in animal models of ischemic stroke, cerebral edema, and multiple sclerosis.
Insights
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 are implicated in central nervous system injury. Inhibiting TWEAK shows therapeutic promise for conditions like ischemic stroke and multiple sclerosis.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a TNF superfamily member.
- TWEAK interacts with its receptor fibroblast growth factor-inducible 14 (Fn14).
- Both TWEAK and Fn14 are expressed in the central nervous system (CNS).
Purpose of the Study:
- To investigate the role of TWEAK/Fn14 signaling in CNS pathologies.
- To evaluate the therapeutic potential of inhibiting TWEAK activity in neurological disorders.
Main Methods:
- Analysis of TWEAK and Fn14 expression in CNS tissues.
- Investigating TWEAK-induced cellular responses, including NF-kappaB activation and cytokine release.
- Evaluating the efficacy of Fn14-Fc fusion protein and anti-TWEAK antibodies in animal models.
Main Results:
- TWEAK and Fn14 expression increases in the CNS following stimuli like cerebral ischemia.
- TWEAK signaling contributes to blood-brain barrier permeability and cell death.
- TWEAK activation of NF-kappaB leads to the release of proinflammatory mediators.
- Inhibition of TWEAK demonstrated therapeutic effects in models of ischemic stroke, cerebral edema, and multiple sclerosis.
Conclusions:
- TWEAK/Fn14 signaling plays a significant role in CNS injury.
- Targeting TWEAK represents a potential therapeutic strategy for various neurological diseases.
Related Concept Videos
Nervous System
Extending...
The Sympathetic Nervous System
Functions of the Nervous System
What is a Nervous System?
Peripheral Nervous System: Ganglia and Nerves
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
Organization of the Nervous System
The CNS, comprising the brain and spinal cord, houses billions of neurons. The brain is housed in the skull, while the spinal cord is linked to the brain through the foramen magnum of the occipital bone and is surrounded by the protective structure of the vertebral column. It is responsible for processing various...

